KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $46.2 million.

  • Pacira BioSciences' Shares Outstanding (Weighted Average) fell 2.59% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year decrease of 2.59%. This contributed to the annual value of $46.2 million for FY2024, which is 0.57% down from last year.
  • Pacira BioSciences' Shares Outstanding (Weighted Average) amounted to $46.2 million in FY2024, which was down 0.57% from $46.4 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Shares Outstanding (Weighted Average) registered a high of $46.4 million during FY2023, and its lowest value of $43.4 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Shares Outstanding (Weighted Average) value was $46.2 million (recorded in 2024), while the average stood at $46.2 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first grew by 4.10% in 2020, then decreased by 0.57% in 2024.
  • Pacira BioSciences' Shares Outstanding (Weighted Average) (Yearly) stood at $43.4 million in 2020, then climbed by 2.53% to $44.5 million in 2021, then increased by 3.00% to $45.9 million in 2022, then rose by 1.21% to $46.4 million in 2023, then declined by 0.57% to $46.2 million in 2024.